NCT04336241 2026-02-27Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsReplimune Inc.Phase 1 Active not recruiting36 enrolled
NCT03025256 2026-01-08Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseM.D. Anderson Cancer CenterPhase 1 Active not recruiting71 enrolled
NCT05812027 2025-11-17A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsTScan Therapeutics, Inc.Active not recruiting1,150 enrolled